COST-EFFECTIVENESS ANALYSIS OF CANCER RISK REDUCTION STRATEGIES FOR BRCA MUTATION CARRIERS

被引：0
|
作者：
Khodorovich, O. S. [1 ]
Solodkiy, V. A. [1 ]
Derkach, E., V [2 ]
机构：
[1] Russian Sci Ctr Roentgenoradiol, Moscow, Russia
[2] Russian Presidential Acad Natl Econ & Publ Adm, Moscow, Russia
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.2226
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN152
引用
收藏
页码：A736 / A736
页数：1
相关论文
共 50 条
  • [41] ANALYSIS OF COST-EFFECTIVENESS OF THROMBOLYTIC STRATEGIES
    LAUNOIS, R
    LAUNOIS, B
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, TOME 82, SPECIAL NO 3: LES GRANDS ESSAIS THROMBOLYTIQUES DANS LINFARCTUS DU MYOCARDE - ENSEIGNEMENTS METHODOLOGIQUES CLINIQUES ET ECONOMIQUES, 1989, : 55 - 62
  • [42] Cost-Effectiveness of Treatment Strategies for High-Risk Prostate Cancer
    Kowalchuk, R. O.
    Breen, W.
    Harmsen, W. S.
    Jeans, E.
    Morris, L. K.
    Mullikin, T. C.
    Miller, R. C.
    Wong, W. W.
    Vargas, C. E.
    Trifiletti, D. M.
    Phillips, R.
    Choo, C. R.
    Davis, B. J.
    Pisansky, T. M.
    Tendulkar, R. D.
    Stish, B. J.
    Waddle, M. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E342 - E342
  • [43] The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers
    Teppala, Srinivas
    Scuffham, Paul
    Edmunds, Kim
    Roberts, Matthew
    Fairbairn, David
    Smith, David
    Horvath, Lisa
    Tuffaha, Haitham
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 208 - 208
  • [44] Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers
    Chubiz, Jessica E. Cott
    Lee, Janie M.
    Gilmore, Michael E.
    Kong, Chung Y.
    Lowry, Kathryn P.
    Halpern, Elkan F.
    McMahon, Pamela M.
    Ryan, Paula D.
    Gazelle, G. Scott
    CANCER, 2013, 119 (06) : 1266 - 1276
  • [45] COST-EFFECTIVENESS ANALYSIS OF GERMLINE BRCA MUTATION TESTING AND OLAPARIB TREATMENT IN METASTATIC BREAST CANCER: AN EVALUATION OF CODEPENDENT TECHNOLOGIES
    Tuffaha, H.
    Scuffham, P.
    VALUE IN HEALTH, 2019, 22 : S454 - S454
  • [46] Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers
    Staton, Ashley D.
    Kurian, Allison W.
    Cobb, Kristin
    Mills, Meredith A.
    Ford, James M.
    FAMILIAL CANCER, 2008, 7 (02) : 179 - 186
  • [47] Ovarian Cancer Risk-Reduction and Screening in BRCA1/2 Mutation Carriers
    Disilvestro, Jessica B.
    Haddad, Jessica
    Robison, Katina
    Beffa, Lindsey
    Laprise, Jessica
    Scalia-Wilbur, Jennifer
    Raker, Christina
    Clark, Melissa A.
    Lokich, Elizabeth
    Hofstatter, Erin
    Dalela, Disha
    Brown, Amy
    Bradford, Leslie
    Toland, Maris
    Stuckey, Ashley
    JOURNAL OF WOMENS HEALTH, 2024, 33 (05) : 624 - 628
  • [48] Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers
    Ashley D. Staton
    Allison W. Kurian
    Kristin Cobb
    Meredith A. Mills
    James M. Ford
    Familial Cancer, 2008, 7 : 179 - 186
  • [49] Social and behavioral risk reduction strategies for tuberculosis prevention in Canadian Inuit communities: a cost-effectiveness analysis
    Uppal, Aashna
    Oxlade, Olivia
    Nsengiyumva, Ntwali Placide
    N'Diaye, Dieynaba S.
    Alvarez, Gonzalo G.
    Schwartzman, Kevin
    BMC PUBLIC HEALTH, 2021, 21 (01)
  • [50] Social and behavioral risk reduction strategies for tuberculosis prevention in Canadian Inuit communities: a cost-effectiveness analysis
    Aashna Uppal
    Olivia Oxlade
    Ntwali Placide Nsengiyumva
    Dieynaba S. N’Diaye
    Gonzalo G. Alvarez
    Kevin Schwartzman
    BMC Public Health, 21
12345